The medRxiv preprint is titled “Lifespan brain structural variation reveals shared organization across mental health conditions” and is registered with DOI https://doi.org/10.64898/2026.08.13.26360304. Correspondence is listed at enigmagradients@gmail.com. The first listed author is Meike D. Hettwer. The manuscript is posted as a clinical preprint and is explicitly indicated as not peer reviewed.
The author list provided is large and international, with institutional affiliations that include the Max Planck Institute for Human Cognitive and Brain Sciences, the Penn Lifespan Informatics and Neuroimaging Center (University of Pennsylvania), Research Center Jülich, Radboud University Medical Centre, and Oslo University Hospital, among many others. Multiple ENIGMA working groups are named directly in the author line (ENIGMA Autism, ENIGMA Anxiety, ENIGMA Bipolar Disorder, ENIGMA Major Depression, ENIGMA OCD, ENIGMA Schizophrenia), suggesting a consortium-based effort spanning several diagnostic groups.
From the title, the study’s stated focus is on lifespan patterns of brain structural variation and how these structural features reveal a shared organization across different mental health conditions. The title implies cross-disorder comparison or integration of structural neuroimaging data across an age span. The presence of multiple ENIGMA disorder groups in the author list supports that the study integrates data from several psychiatric conditions.
The source material supplied for this rewrite does not include the manuscript abstract, introduction text, or any section describing aims, hypotheses, or outcomes beyond the title. Therefore, the specific hypotheses tested, brain metrics used (for example, cortical thickness, volume, surface area, subcortical metrics), age ranges, sample sizes, imaging modalities, preprocessing pipelines, or statistical models are not reported in the provided text.
The manuscript lists a very large number of contributing investigators across many institutions and countries. Several major neuroimaging and psychiatric research centers are named in the affiliations attached to authors. The explicit inclusion of ENIGMA working groups indicates coordination with established, disorder-specific meta-analytic and mega-analytic consortia in psychiatric neuroimaging.
Because only the author names and institutional affiliations appear in the provided excerpt, detailed information on which groups contributed which datasets or the geographic and demographic composition of the pooled samples is not available in the supplied text.
This work is available as a medRxiv preprint and is unrefereed at the time of posting. The DOI for the preprint is provided above. The medRxiv page contains the standard disclaimer that the manuscript reports new medical research that has yet to be evaluated and should not be used to guide clinical practice.
For correspondence or queries about the manuscript, the provided contact is enigmagradients@gmail.com. The first and corresponding authors and many contributing institutions are listed on the medRxiv page.
What is reported in the supplied material:
What is not reported in the supplied material (details not present in the source text provided):
Because these items are absent from the provided excerpt, they cannot be summarized or paraphrased here. Any interpretation of specific results, effect magnitudes, or clinical utility would require access to the full preprint text or supplementary materials.
Implications: The title and consortium composition indicate the manuscript addresses important questions about how structural brain differences vary across the lifespan and how such variation may map onto multiple psychiatric diagnoses. If confirmed, such findings could inform research on shared neurobiological organization across disorders and developmental windows of vulnerability. However, the specific clinical implications cannot be assessed from the supplied text.
Limitations and caution: The manuscript is a preprint and has not completed peer review. The supplied source excerpt lacks methodological and results details necessary to evaluate validity, generalizability, effect sizes, and potential confounders. Until peer review and independent replication are available, the findings should not be used to change clinical practice.
Next steps to evaluate the study: To assess the study’s methods and conclusions, obtain the full medRxiv preprint using the DOI above or contact the corresponding address for data and methodological details. Key items to review will include sample composition, imaging and harmonization methods, statistical controls for confounders (age, sex, site, image quality), how cross-disorder shared organization was defined and tested, and any replication or sensitivity analyses reported by the authors.
For clinicians and researchers interested in cross-disorder neuroimaging and lifespan effects, monitoring the peer-review outcome and any follow-up publications or dataset releases will be important before translating these findings into practice or further clinical study design.